Drug intelligence / Profile preview

Bohm solution

Development stage
Unknown
Lead developer
Laboratorios Bohm
Modality
Small Molecules
Administration
Intracardiac
01

Overview

Bohm solution is a sterile, non-pyrogenic cardioplegic solution used primarily in cardiac surgery to induce and maintain elective cardiac arrest. Developed by Laboratorios Bohm, it is administered via the coronary arteries or the aortic root during cardiopulmonary bypass to protect the myocardium during the ischemic period of surgery. The solution's mechanism of action is multifaceted: it contains a high concentration of potassium ions to depolarize the myocardial cell membrane, thereby arresting the heart in diastole and significantly reducing metabolic demand. Additionally, it incorporates magnesium chloride, which acts as a physiological calcium antagonist to stabilize the membrane and prevent calcium overload, and procaine hydrochloride, a local anesthetic that blocks voltage-gated sodium channels to further inhibit electrical activity and provide additional myocardial protection.

Brand names
Solución BohmSolución Bohm para Cardioplegia
Other names
Bohm cardioplegic solutionBohm's solution
02

Targets

HTR3A (5-hydroxytryptamine receptor 3A)KCNN1 (Small conductance calcium-activated potassium channel protein 1)DNMT1 (DNA (cytosine-5)-methyltransferase 1)DNMT3A (DNA methyltransferase 3 alpha)GRIN3A (Glutamate receptor ionotropic, NMDA subunit 3A)CHRNA2 (nAChR α2)SCN10A (Sodium channel protein type X alpha subunit)DAT (Dopamine plasma membrane transport protein)

Beyond the preview

Go deeper on Bohm solution.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bohm solution.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call